Skip to main content
Jenkem Technology Co., Ltd. logo

Jenkem Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688356 ISIN · CNE1000043K9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 569 across all filing types
Latest filing 2022-12-06 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688356

About Jenkem Technology Co., Ltd.

https://www.jenkem.com/

Jenkem Technology Co., Ltd. specializes in the research, development, and large-scale manufacturing of high-purity polyethylene glycol (PEG) derivatives and related polymers. The company provides a comprehensive portfolio of PEG products, including monodisperse and polydisperse PEG linkers, multi-arm PEGs, and functionalized derivatives such as NHS esters, maleimides, and amines. These materials are primarily utilized in advanced drug delivery systems, PEGylation of proteins and peptides, and the development of medical devices and hydrogels. In addition to its core PEG offerings, the company produces biodegradable polymers, including PLA, PLGA, and PCL. Jenkem Technology supports the global biotechnology and pharmaceutical sectors through custom synthesis and high-quality manufacturing processes designed to meet rigorous technical specifications for therapeutic and diagnostic applications.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（毕克）
Board/Management Information Classification · 95% confidence The document is a nomination statement for an independent director candidate, detailing qualifications, compliance with regulatory requirements, and independence criteria. It does not contain financial data, audit results, or report content. It is not an announcement of a report publication but a formal declaration related to board/management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on director nomination, confirming this classification.
2022-12-06 Chinese
关于召开2022年第三季度业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the scheduling and details of a 2022 third quarter earnings explanation meeting (业绩说明会) for Beijing Jienkai Technology Co., Ltd. It specifies the date, time, location, participants, and how investors can participate and ask questions. It references the previously published 2022 third quarter report but does not contain the report itself or detailed financial data. The document is short (1389 characters) and serves as a notice for an upcoming earnings call or presentation rather than the actual financial report or transcript. Therefore, it fits best as a Call Transcript (CT) announcement or an Investor Presentation (IP) announcement. However, since it is about an earnings explanation meeting (业绩说明会) and not the transcript itself, and it is an announcement of the meeting, the best classification is Investor Presentation (IP).
2022-11-17 Chinese
关于自愿披露注射用聚乙二醇伊立替康用于治疗脑胶质瘤II期临床试验完成首例受试者入组的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Beijing JianKai Technology Co., Ltd. regarding the completion of the first patient enrollment in a Phase II clinical trial for a drug developed by the company. It provides details about the drug, the clinical trial progress, and risk warnings. The document is short (1066 characters) and does not contain financial statements, earnings data, or detailed financial analysis. It is an update on a clinical trial progress rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is an announcement of a significant development related to the company's R&D project, which is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2022-11-11 Chinese
第二届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Jiankai Technology Co., Ltd. regarding the approval of the company's 2022 third quarter report, adjustments to investment projects, and purchase of liability insurance for directors and senior management. It references the third quarter report but does not contain the report itself or detailed financial data. The document is relatively short (1567 characters) and serves as an official announcement of meeting decisions and approvals rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice rather than an Interim/Quarterly Report (IR) or other specific report type.
2022-10-30 Chinese
中信证券股份有限公司关于北京键凯科技股份有限公司变更增加部分募投项目投资规模并使用超募资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the verification and opinion on the change and increase in the investment scale of certain fundraising projects and the use of excess fundraising funds by Beijing Jiankai Technology Co., Ltd. It includes detailed financial figures, project descriptions, board and supervisory opinions, and compliance with regulatory requirements. The document references regulatory guidelines and approvals related to fundraising and investment projects, and it is not a simple announcement but a comprehensive verification report. This fits the category of an Audit Report / Information (AR), as it involves audit and verification opinions on the use of funds and project changes, rather than a full annual report or a simple announcement. The document length (5574 characters) and content support this classification with high confidence. Q4 2022
2022-10-30 Chinese
北京键凯科技股份有限公司《公司章程修正案》
Governance Information Classification · 95% confidence The document is titled '公司章程修正案' which translates to 'Amendment to the Articles of Association' and details changes to the company's registered capital and corresponding amendments to the company bylaws. It references board and supervisory meetings approving these changes and mentions subsequent registration with the relevant authorities. There is no financial data, earnings information, or report publication mentioned. The content is about governance structure and company internal rules amendments, specifically the articles of association. Therefore, this fits the category of Governance Information (CGR). The document length is short but contains substantive governance content, not just an announcement or notice.
2022-10-30 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.